Patient Support

• Osteoporosis Information
• Osteoporosis Resources
• Breast Cancer Resources

Osteoporosis Information
The educational materials available here for download can help your patients better understand osteoporosis and how to manage the disease.

To download a FREE copy of Adobe^® Reader^®, click here.

Looking Toward Better Bone Health — A Comprehensive Overview
Knowledge is your first step in taking charge against osteoporosis. This brochure contains all of the resources found in the fact sheets below, including information on osteoporosis, risk assessment, how to build your body and bones, reducing your risk of falls, and eating healthy.

Know More About Osteoporosis
Osteoporosis is a serious disease, and is often "silent" with few warning signs and symptoms. Since you may not even know you have osteoporosis until you break a bone, now is the time to learn more about the disease, and if you are at risk.

Assess Your Risk and Work With Your Doctor
Fill out this handy checklist and take it with you when discussing your health with your healthcare professional. Also provided are questions which can help your healthcare professional assess your risk and determine an appropriate treatment or prevention plan.

Build Your Body and Your Bones
Bone is living tissue that responds to exercise by becoming stronger and denser. Learn more about the importance of a regular exercise program, and the different types of exercise that might be right for you.

Protect Your Bones With Calcium and Vitamin D
Calcium is a mineral that promotes good bone health and is particularly important for postmenopausal women who are at increased risk of osteoporosis. Learn more about calcium, and how adequate levels of vitamin D are needed for optimal calcium absorption.

Reduce Your Risk of Falls
Preventing falls is an important part of decreasing your risk of osteoporotic fractures both outside and inside your home. These practices will help reduce your risk of falls wherever you go, and will help you specifically identify potential dangers throughout your house.

Eat Healthy for Stronger Bones
Healthy eating is essential to maintaining strong, healthy bones. A healthy diet is based on choosing a variety of foods from each of the basic food groups and getting the right nutrients. Learn about these groups and how to read nutrition labels here.

Osteoporosis Resources
For those patients wanting to learn more about osteoporosis, we recommend a few of the resources available on preventing, treating, and living with this disease.

About Osteoporosis

National Institutes of Health, Osteoporosis and Related Bone Diseases — National Resource Center
800-624-BONE or 202-223-0344
http://www.osteo.org

National Osteoporosis Foundation (NOF)
800-231-4222 or 202-223-2226
www.nof.org

U.S. Surgeon General's Report on Bone Health and Osteoporosis
http://www.surgeongeneral.gov/library/bonehealth

General Women's Health

National Women's Health Resource Center (NWHRC)
877-986-9472
http://www.healthywomen.org

Department of Health and Human Services, Office of Women's Health
National Women's Health Information Center
800-994-9662
http://www.4woman.gov

Nutrition

American Dietetic Association (ADA)
800-366-1655 (Consumer Nutrition Information and Referral)
http://www.eatright.org

National Digestive Diseases Information Clearinghouse
800-891-5389 or 301-654-3810
http://www.digestive.niddk.nih.gov

Exercise

American College of Sports Medicine (ACSM)
317-637-9200
http://www.acsm.org

Aging

Alliance for Aging Research
202-293-2856
http://www.agingresearch.org

National Institutes of Health (NIH) National Institute on Aging (NIA)
301-496-1752
http://www.nia.nih.gov

Social Organizations

General Federation of Women's Clubs (GFWC)
800-443-GFWC (800-443-4392)
http://www.gfwc.org

Breast Cancer Resources
For those patients wanting to learn more about breast cancer, we recommend a few of the resources available online.

American Cancer Society
1-800-ACS-2345 (800-881-2345)
http://www.cancer.org

National Cancer Institute
1-800-4CANCER (800-422-6237)
http://www.cancer.gov

National Breast Cancer Coalition
800-622-2838
http://www.stopbreastcancer.org

The Susan G. Komen Breast Cancer Foundation
800-I'M AWARE (800-462-9273)
http://www.komen.org

Y-Me National Breast Cancer Organization
800-221-2141
http://www.y-me.org

Young Survival Coalition
877-YSC-1011 (877-972-1011)
http://www.youngsurvival.org

Privacy Statement | Terms of Use | Copyright

©2008 Eli Lilly and Company. All Rights Reserved. This site is intended for U.S. residents age 18 and over.
EVISTA is a registered trademark of Eli Lilly and Company.
RA-45621

Important Safety Information for EVISTA

Contraindications
EVISTA is contraindicated in nursing women and in women who are or may become pregnant, as it may cause fetal harm. EVISTA is also contraindicated in women with active or past venous thromboembolic events (VTEs), including deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis.

Warnings and Precautions
In a study of postmenopausal women at high risk for cardiovascular disease taking EVISTA, there was no increase in the incidence of stroke; however, there was an increase in death due to stroke. EVISTA also did not increase or decrease the incidence of overall mortality, cardiovascular mortality, or heart attack. The risk-benefit balance should be considered in women at risk for stroke, such as those with prior stroke or transient ischemic attack (TIA), atrial fibrillation, hypertension, or cigarette smoking. EVISTA should be used with caution in patients with hepatic impairment or moderate/severe renal impairment since safety and efficacy have not been established in these patients. The safety of concomitant use of EVISTA with systemic estrogens has not been established and its use is not recommended.

Adverse Reactions
The common adverse reactions considered to be drug related:

Adverse reactions occurring in the clinical trials at a frequency ≥2.0% in either group and in more EVISTA-treated women than in placebo-treated women include:

The majority of adverse reactions occurring during the osteoporosis prevention and treatment studies were mild and generally did not require discontinuation of therapy.

Please see Contraindications, Warnings and Precautions, and Adverse Reactions sections of full Prescribing Information for other Important Safety Information.